Executive Summary
Tesla, Inc. successfully convinced the PTAB that its claims against Intellectual Ventures II LLC were likely unpatentable based on prior art references Matsushima and Yu/Miyazaki. The Board granted institution, moving the dispute toward trial over key terms like 'integration time' in dynamic range camera technology.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Tesla, Inc. vs Intellectual Ventures II is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
United Services Automobile AssociationvsAuto Telematics Ltd.
United Services Automobile Association (USAA) successfully argued that the patent claims related to telematics and driving safety systems were obvious under 35 U.S.C. § 103. The PTAB found a reasonable likelihood of prevailing on its assertion, advancing the IPR proceedings against Auto Telematics Ltd.'s '878 patent.
Google LLCvsSecure Communication Technologies, LLC
The PTAB denied institution for Google LLC's IPR against Secure Communication Technologies regarding patent 11995685. The Board found that the petitioner failed to demonstrate a reasonable likelihood of prevailing on any challenged claims.
Ericsson Inc. et al.vsActive Wireless Technologies LLC
Ericsson and Nokia successfully petitioned to institute an IPR against Active Wireless Technologies LLC regarding 5G NR PUCCH design claims. The Board found compelling evidence of unpatentability, despite initial concerns raised by the Patent Owner's arguments.
Sarepta Therapeutics, Inc et al.vsThe Trustees of the University of Pennsylvania et al.
Sarepta Therapeutics, Inc. successfully challenged several claims of The Trustees of the University of Pennsylvania in an IPR proceeding regarding gene therapy/AAV technology. The Board found a reasonable likelihood of prevailing on multiple grounds of obviousness (35 U.S.C. § 103) using combinations of prior art references.
Arthrex, Inc. et al.vsMedshape, Inc.
The PTAB denied Arthrex's IPR petition against Medshape's patent (7985222), citing the complex and overlapping nature of co-pending district court litigation.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.